Purchase access and get detailed insights on all of the companies below via CEO presentations (audio and slides), executive summaries, and much more. Plus leverage our private partnering tool to request additional information and meetings with CEOs.
AMB Surgical II - AMB Surgical's groundbreaking, patented technology is intended to reduce the necessity for invasive and repetitive surgery in children and teens with orthopedic deformities such as scoliosis and limb abnormalities. FLYTE™ smart automated growing rod technology is a sophisticated electro-mechanical, software activated device to provide real-time biomechanical feedback to guide treatment, as well as, allow surgeons to perform accurate, non-surgical skeletal adjustments.
(View Sample Presentation) C. Light Technologies, Inc. - C. Light Technologies is a neurotech and machine learning company that uses novel eye motion technology to revolutionize the detection, monitoring, and treatment of neurodegenerative diseases (starting with multiple sclerosis). We apply advanced machine learning algorithms to the patterns of eye motion to provide objective and clinically actionable metrics in order to monitor disease progression and drug efficacy. With eye-tracking technology 120-150x better than commercially available pupil trackers, the TSLO generates 10+ data points that have never previously existed, which can be commoditized and advance medical science. Future Applications include: Alzheimer's, Parkinson's, and concussions.
(View Sample Presentation) CorFigo - We are an early stage medical device company developing a product called the HeArTPAD™ intended to treat persistent atrial fibrillation. It is a novel, minimally invasive, video-guided surgical approach (sub-xiphoid or laparoscopic/trans-diaphragmatic) to ablate the posterior wall of the left atrium that can be used concomitantly with an EP catheter ablation. The HeArTPAD Cryo-Ablation System will employ a continuous, high flow rate of very cold gas through a maze like pattern within a broad, flat pad to ablate atrial tissue and overcome the heat sink of blood flowing within the left atrium.
(View Sample Presentation) DermaSensor Inc - DermaSensor, Inc. is a connected device company that enables healthcare professionals to efficiently check for skin cancer by leveraging cutting edge technologies. The DermaSensor device is an affordable handheld tool that uses artificial intelligence and spectroscopy to evaluate skin lesions for potential skin cancer in a matter of seconds.
(View Sample Presentation) Empirical Spine - LimiFlex is a lumbar spinal implant for sciatica patients suffering from degenerative spondylolisthesis (DS), the most common diagnosis leading to lumbar spinal fusion. Current treatments for DS include standalone decompression, with a high risk of recurrence, or decompression plus fusion, a highly invasive surgery with higher morbidity and increased risk of adjacent segment degeneration. LimiFlex offers the benefits of segmental stability, like fusion, while preserving motion, reducing long-term risk, procedure invasiveness, and recovery time. In addition, LimiFlex is usually performed as an outpatient procedure, matching the current clinical trends and saving cost while increasing patient satisfaction. LimiFlex is completely reversible and thus preserves future surgical options.
(View Sample Presentation) Epic Neuro - An early stage medical device company built around a patented minimally invasive brain stimulation technology used in stroke rehabilitation. The miniature-sized EPIC device is inserted into a burr hole in the skull and is externally powered, providing stimulation to either cortical or deep structures. EPIC is far less invasive than existing technology with a much shorter procedure, lower cost, fewer complications, and faster recovery time. It involves no tunneled leads or battery changes, and is easily removable.
(View Sample Presentation) Forest Devices - Pre-hospital stroke identification--an ECG for the brain.
(View Sample Presentation) Green Sun Medical - Green Sun Medical was founded to develop innovative treatments to address Adolescent Idiopathic Scoliosis and Kyphosis. We are developing a dynamic orthotic that will aid in correcting these spinal deformities. The Green Sun Medical device is the first orthotic to address directly the complex biomechanics of Adolescent Idiopathic Scoliosis (AIS). Additionally Bluetooth connected sensors will allow patients and physicians to ensure proper treatment is being provided.
(View Sample Presentation) Healthup Sp. z o.o. - AioCare device is a personal, connected and ultra-portable spirometer with a dedicated mobile application for a smartphone. The device is capable of measuring all important and widely used spirometry parameters including: FVC, FEV1, FEV1/FVC, PEF, FEF 25-75, etc. Additionally, the device measures heart rate and ambient environmental conditions (temperature, humidity, and pressure). AioCare works with iOS and Android operating systems. It is designed for self-monitoring by patients suffering from asthma, COPD and cystic fibrosis. AioCare is also available for physicians to examine their patient's spirometry parameters in-hospital/outpatient settings, with examination results available in the application and the AioCare Health Cloud.
(View Sample Presentation) HIL Applied Medical - HIL Applied Medical is developing ultra-compact, high-performance systems for cancer Proton Therapy.
(View Sample Presentation) Histologics - Histologics manufactures and markets Internationally multi-patented evidence-based (proven) and burgeoning commercialized technology to acquire a-traumatic mucosal biopsies and perform less traumatic wound care debridement. This replaces traumatic sharp instruments with a patient friendly brush-biopsy approach. The devices employ a proprietary medical fabric "Kylon®", attached to several applicator devices to allow for minimally invasive trans-epithelial and dermal tissue sampling/biopsy and the automatic trapping of specimens for easy transport for laboratory analysis.
(View Sample Presentation) LifeHealth - LifeHealth is one of only three companies in the world that manufactures bedside point of care blood gas analysis systems. LifeHealth has recently released a new, best in class analyzer and is early in development on a new, best in class single use disposable cartridge. This new solution will lead to significant penetration of the point of care critical care blood diagnostics market segment.
(View Sample Presentation) LivOnyx Inc. - LivOnyx Inc. is developing a rapid hand disinfection system to reduce healthcare associated infections (HAIs) using its proprietary, patented thinSpray technology and antiseptic LVNX-001. There is an unmet need for a hand hygiene solution that takes no more than 3-5 seconds, leaves hands dry, facilitates hand health, is portable to optimize workflow around the patient, and is effective against the pathogen Clostridium difficile, a leading cause of HAIs in hospitals.
(View Sample Presentation) MobileODT - We create smart, connected visual assessment solutions for women's health clinicians to screen for cervical cancer and replace expensive and time-consuming laboratory tests with point-of-care AI-based decision support.
(View Sample Presentation) NanoVault Medical - Cellular & Biotherapeutics Delivery: utilizing nanotechnology-derived materials to address chronic and costly diseases, These include diabetes related insulin- dependency, a near 100 year old, $43 Billion industry.
(View Sample Presentation) Paragate Medical Ltd. - Paragate Medical is an innovative device company, aiming to revolutionize heart failure management by introducing the first ever fully implantable device to actively and continuously prevent fluid overload in congestive heart failure patients.
(View Sample Presentation) Serenno Medical - Serenno Medical is developing a robust, hands free, automatic and low cost Urine Output monitoring device for the ICU, assisting in AKI detection and prevention.
(View Sample Presentation) Vascular Genesis - Vascular Genesis is building a vascular regeneration platform with its line of cell-free, synthetic scaffold products, eliminating the need for tissue donation, immune suppressants, and the ever-present risk of transplant rejection. Our first product offering is a resorbable arteriovenous (AV) graft for dialysis access. The graft will degrade over a scheduled period of time and allow the body to create a new native tissue fistula for continual dialysis access. The graft is designed to match the compliance of the native artery/vein to which it attaches. Its self-healing capabilities will allow it to achieve stasis (stop bleeding) faster than competing products.
(View Sample Presentation) VerteCore Technologies - VerteCore Technologies is a medical device development company which creates products addressing orthopedic niche markets. Thru creating innovative medical devices for ambulatory, non-surgical treatment of spinal disorders, we offer a novel approach to back and neck pain treatment, enabling rapid recovery while helping eliminate the need for hospitalization, drugs, and surgery. Three versions of the company's lead device have already been designed with the participation of leading physicians in the orthopedic field. Multiple Patent Pending statuses have been obtained and patent assignment provided into the company.
(View Sample Presentation) Voxello - Voxello develops pioneering technology providing severely impaired patients the ability to communicate with caregivers and family effectively. Voxello developed the noddle® and noddle-chat to reduce adverse events, achieve better outcomes, and improve patient satisfaction while returning a sizable ROI to the hospital. Using any voluntary gesture such as a tongue click or minimal movement such as a head nod, a patient can access the nurse call and the noddle-chat, which is a speech generation device to communicate.
(View Sample Presentation) TBA - More companies coming soon
Sample EMT Spotlight Profile
Below is a sample profile from our last event. This type of insight is available for every company being profiled in our upcoming Spotlight.
Presenter: Boaz Assaf, CEO Financing Status: Seeking Funding Round: Series C Amount: $6-$8M Development Status: CE Marked, Pilot clinical trial completed ready to launch FDA pivotal trial Sales Projection: $7,725,000 in 2021 Seeking Partners: Financing, M&A, Licensing
Need help finding medtech research? Let us help you!